Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Hang Seng Index on course for weekend rally as oil prices recover

The Hang Seng Index regained some of the value lost in the oil price crisis, but failed coronavirus drug trials bring downward movement ahead of the weekend.

China trading Source: Bloomberg

The Hang Seng Index opened Friday trading 0.6% down on its previous close, starting the day at 23,844.55. That downward trend continued in the early trading hours, with the index making a brief stop below 23,750.00.

A challenging week ended with the Hang Seng Index recouping some of the losses from its morning performance, entering the weekend of trading at 23,886.03.

Oil was the dominant factor behind Hang Seng fluctuations earlier in the week, with crude prices reaching new lows and causing panic among investors.

The index appeared to be rallying alongside oil prices as the week progressed, although some of that recovery has been undermined by the Friday news that a potential antiviral drug for coronavirus has failed in its first clinical trial.

Hang Seng and oil rebound from Tuesday woes to deliver short-term optimism; long-term outlook remains bleak

This week witnessed the biggest daily fall on the Hang Seng Index in around a month. As West Texas Intermediate (WTI) crude futures sank below zero for the first time in history, the Hang Seng Index shed 2.2% on 21 April.

Negative prices meant that the WTI, the US benchmark for oil prices, had to pay traders to take the oil off their hands as part of the May contract. This unprecedented event unsettled investors, with the Hang Seng Index declining as traders sought to remove their exposure to assets affected by the continuing crude crisis.

WTI and Brent, the global benchmark, recovered some recent losses as the week progressed, with major stock indices similarly able to make gains. The Hang Seng Index ended with an overall 2% decrease in the week of trading, but rose by 0.04% following that Tuesday low.

The Hang Seng Index may enjoy a respite from oil-driven losses, at least until the expected issues about fulfilling June contracts arise.

Failed coronavirus drug trials set to shrink global markets, derailing the late-week rally of the Hang Seng Index

This time last week, the Hang Seng Index was heading into the weekend with reason for cautious optimism towards the pandemic response.

Positive noises were emanating from the clinical trials undertaken by Gilead Sciences, the American pharmaceutical company. On Friday 24 April, markets reacted to the news that these trials had proven unsuccessful.

The World Health Organisation erroneously posted a draft report that showed that the China-based trial of the drug remdesivir had failed. The WHO subsequently took down that report, but its findings provoked that 0.6% fall on the Hang Seng Index at Friday's open.

The summary of the report stated that 'remdesivir was not associated with clinical or virological benefits'.

Gilead has countered the WHO's conclusions, declaring that further trials are required before ruling out the use of remdesivir. A spokesperson for Gilead indicated that 'trends in the data suggest a potential benefit' for the antiviral drug.

The quest for a medical solution to the spread of coronavirus will be an ongoing theme in market movements in the weeks and months ahead. While the news of the failed trial initially caused the Hang Seng Index to retract, the market may recover over the weekend as traders adjust their expectations about when a coronavirus vaccine may emerge.

Market acceptance of the remdesivir news could send the Hang Seng Index back on course for a weekend rally from its plunge earlier in the week.

While the long-term picture for oil remains bleak, prices are unlikely to drop below zero again in the immediate future. This could give the Hang Seng Index a platform over the weekend to continue to recoup its weekly losses.

How much does it cost to buy UK shares with IG?

There are three ways to ‘buy’ UK shares with IG: spread betting, trading CFDs or buying physical shares. The cost will depend on which method you choose. The table below illustrates how the costs to get exposure to £10,000 of Lloyds stock, which is equivalent to 16,000 shares (quoted at 62.5p a share).

Remember, spread bets and CFDs are derivatives, which come with higher risk and reward than investing.

Cost to get exposure to Lloyds stock

Spread betting CFD trading Share dealing
Action Buy £160 per point Buy 16,000 share CFDs Buy 16,000 shares
Capital required to open £2000 £2000 £10,000
Total fees £20.88 £20.88 £16

Ready to start trading shares? Open a live account or practise on a demo.

Note: Amounts do not include overnight funding charges and taxes. Spread bets are not subject to tax. CFDs are free from stamp duty, but subject to capital gains tax. Share dealing is subject to both stamp duty and capital gains tax.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.